Joseph S. Ross

30.4k total citations · 6 hit papers
612 papers, 19.3k citations indexed

About

Joseph S. Ross is a scholar working on Economics and Econometrics, General Health Professions and Pharmacology. According to data from OpenAlex, Joseph S. Ross has authored 612 papers receiving a total of 19.3k indexed citations (citations by other indexed papers that have themselves been cited), including 304 papers in Economics and Econometrics, 142 papers in General Health Professions and 101 papers in Pharmacology. Recurrent topics in Joseph S. Ross's work include Health Systems, Economic Evaluations, Quality of Life (177 papers), Pharmaceutical Economics and Policy (136 papers) and Pharmaceutical industry and healthcare (97 papers). Joseph S. Ross is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (177 papers), Pharmaceutical Economics and Policy (136 papers) and Pharmaceutical industry and healthcare (97 papers). Joseph S. Ross collaborates with scholars based in United States, Canada and United Kingdom. Joseph S. Ross's co-authors include Harlan M. Krumholz, Nilay D. Shah, Susannah M. Bernheim, Zhenqiu Lin, Elizabeth E. Drye, Jersey Chen, Sharon‐Lise T. Normand, Nicholas S. Downing, Cary P. Gross and Sanket S. Dhruva and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Joseph S. Ross

564 papers receiving 18.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures

2009 996 citations Harlan M. Krumholz, Joseph S. Ross et al. profile →
Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia

2013 806 citations Joseph S. Ross, Elizabeth E. Drye et al. JAMA profile →
An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure

2008 418 citations Sharon‐Lise T. Normand, Elizabeth E. Drye et al. profile →
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012

2014 301 citations Nilay D. Shah, Harlan M. Krumholz et al. JAMA profile →
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

2019 220 citations Joseph S. Ross et al. Annals of Internal Medicine profile →
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

2020 220 citations Sanket S. Dhruva, Joseph S. Ross et al. JAMA profile →

Peers

Countries citing papers authored by Joseph S. Ross

Since Specialization

Citations

This map shows the geographic impact of Joseph S. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph S. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph S. Ross more than expected).

Fields of papers citing papers by Joseph S. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph S. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph S. Ross. The network helps show where Joseph S. Ross may publish in the future.

Co-authorship network of co-authors of Joseph S. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph S. Ross. A scholar is included among the top collaborators of Joseph S. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph S. Ross. Joseph S. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers 2025 ·JAMA Oncology ·Chungsoo Kim, Michaela A. Dinan, Timothy J. Robinson, Joseph S. Ross, Ania M. Jastreboff, Harlan M. Krumholz, Yuan Lu	0
2	Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists 2025 ·JAMA Health Forum ·(unknown), (unknown), Reshma Ramachandran, Joseph S. Ross, (unknown)	4
3	Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice 2025 ·Ophthalmology Retina ·Andrew J. Barkmeier, Yihong Deng, (unknown), Jeph Herrin, Eric C. Polley, Guillermo E. Umpierrez, Rodolfo J. Galindo, Joseph S. Ross, (unknown), Rozalina G. McCoy	1
4	Industry Payments to US Physicians by Specialty and Product Type 2024 ·JAMA ·Ahmed Sayed, Joseph S. Ross, John Mandrola, Lisa Soleymani Lehmann, Andrew Foy	12
5	Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data 2024 ·Journal of Pharmaceutical Policy and Practice ·Omar Qureshi, Reshma Ramachandran, Joseph S. Ross	1
6	Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks 2024 ·BMC Cardiovascular Disorders ·Yuan Lu, Ellen C. Keeley, (unknown), Rhonda M. Cooper‐DeHoff, Sanket S. Dhruva, (unknown), (unknown), (unknown), Chenxi Huang, Harlan M. Krumholz, Caitrin W. McDonough, Wade L. Schulz, Kathryn Shaw, (unknown), Jennifer Woodard, Patrick Young, (unknown), Joseph S. Ross	1
7	Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk 2024 ·Clinical Journal of the American Society of Nephrology ·Joshua J. Neumiller, Jeph Herrin, (unknown), Eric C. Polley, Rodolfo J. Galindo, Guillermo E. Umpierrez, Yihong Deng, Joseph S. Ross, (unknown), Rozalina G. McCoy	2
8	Association of health benefits and harms of Christmas dessert ingredients in recipes from The Great British Bake Off: umbrella review of umbrella reviews of meta-analyses of observational studies 2023 ·BMJ ·Joshua D. Wallach, (unknown), Reshma Ramachandran, Joseph S. Ross	0
9	Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018 2023 ·SHILAP Revista de lepidopterología ·Vinay K. Rathi, (unknown), Sanket S. Dhruva, Joseph S. Ross	2
10	Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults 2023 ·JAMA Network Open ·Tasce Bongiovanni, Siqi Gan, Emily Finlayson, Joseph S. Ross, James D. Harrison, W. John Boscardin, Michael A. Steinman	7
11	US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019 2023 ·JAMA Network Open ·Meera M. Dhodapkar, Joseph S. Ross, Reshma Ramachandran	1
12	Physician responses to apple watch-detected irregular rhythm alerts 2023 ·American Heart Journal ·Patrick Demkowicz, Sanket S. Dhruva, Erica S. Spatz, Alexis L. Beatty, Joseph S. Ross, Rohan Khera	5
13	Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review 2023 ·Journal of Clinical Epidemiology ·Anthony Muchai Manyara, Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Valerie Wells, Jane Blazeby, Nancy J. Butcher, Sylwia Bujkiewicz, An‐Wen Chan, Gary S. Collins, Dalia Dawoud, Martin Offringa, Mario Ouwens, Joseph S. Ross, Rod S Taylor, Oriana Ciani	12
14	Research misconduct as a challenge for academic institutions and scientific journals 2023 ·Journal of Epidemiology & Community Health ·Cristina Candal‐Pedreira, Joseph S. Ross, Ana Marušić, Alberto Ruano‐Raviña	0
15	Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges 2023 ·European Heart Journal ·Faı̈ez Zannad, Filippo Crea, John F. Keaney, Stuart Spencer, Joseph A. Hill, Marc A. Pfeffer, Stuart Pocock, (unknown), Joseph S. Ross, Chana A. Sacks, Harriette G.C. Van Spall, (unknown), Mariell Jessup	6
16	US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018 2021 ·Clinical Trials ·(unknown), Audrey D. Zhang, Sanket S. Dhruva, Joseph S. Ross, Joshua D. Wallach	19
17	Patterns of Opioid Prescribing among Medicare Advantage Beneficiaries with Pain and Cardiopulmonary Conditions 2020 ·Journal of Palliative Medicine ·Shelli L. Feder, Maureen Canavan, Shi‐Yi Wang, Erin E. Kent, Jennifer Kapo, Carolyn J. Presley, Joseph S. Ross, Amy J. Davidoff	2
18	Association between FDA black box warnings and Medicare formulary coverage changes. 2017 ·PubMed ·Sanket S. Dhruva, Pinar Karaca‐Mandic, Nilay D. Shah, Daniel L Shaw, Joseph S. Ross	5
19	Observation encounters and subsequent nursing facility stays. 2015 ·PubMed ·Anita Vashi, (unknown), Christopher A. Powers, Joseph S. Ross, William H. Shrank	1
20	Recognition of Endotoxin in Biologic Systems. Keystone Symposia on Molecular and Cellular Biology. March 1-7, 1992. Abstracts. 1992 ·Annals of Internal Medicine ·Elizabeth E. Drye, Sharon‐Lise T. Normand, Yun Wang, Joseph S. Ross, Geoffrey C. Schreiner, Lein Han, Michael Rapp, Harlan M. Krumholz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact